Giovanni Fucà

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Gabriele Martelli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

siranoush manoukian

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Maurizio Colecchia

Professor

Università Vita Salute San Raffaele

ITALY

View details

Massimo Di Nicola

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Caterina Sposetti

Dana-Farber Cancer Institute

UNITED STATES

View details

Filippo Guglielmo Maria de Braud

Professor

Università di Milano

ITALY

View details

Laura Boldrini

European Institute of Oncology

ITALY

View details

Gaia Griguolo

University of Padua

ITALY

View details

Antonia Martinetti

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Licia Rivoltini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanni Fucà

Research Interests

Explore related searches

Contact this professor

Articles (10)

Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial.

Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: different biological and clinical entities with potentially diverse therapeutic opportunities.

Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.

The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.

Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.

Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.

Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.

Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial.

Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study).

BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.

Collaborators (10)

Gabriele Martelli

siranoush manoukian

Maurizio Colecchia

Massimo Di Nicola

Caterina Sposetti

Filippo Guglielmo Maria de Braud

Laura Boldrini

Gaia Griguolo

Antonia Martinetti

Licia Rivoltini

Make your next move.